FirstTake on Pharma - Pharma News and Analysis Podcast
52 episodes - English - Latest episode: over 2 years ago - ★★★★★ - 2 ratingsThe FirstTake - FirstWord's editors discuss the latest pharma news and offer insights from industry experts and KOLs. Designed for the busy pharma industry professional. Visit us at beta.firstwordpharma.com to sign up for newsletters delivering timely news and event-driven physician intelligence.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Oral Inflammatory Drugs At Key Inflection Points
February 12, 2021 23:30 - 35 minutes - 26.4 MBFirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the week’s most important news in pharma and biotech including the latest developments for COVID-19 vaccines and antibody therapeutics, safety concerns for the JAK inhibitor class, the potential opportunity for Bristol Myers Squibb’s Tyk-2 inhibitor in psoriasis and why the FDA has turned down a new approval for Merck & Co.’s Keytruda. They also look ahead to this weekend’s ASCO-GU meeting. ...
Frazier's Keytruda-shaped legacy at Merck
February 08, 2021 23:00 - 29 minutes - 22.2 MBFirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the week’s most important news in pharma and biotech including Pfizer’s revenue expectations for its COVID-19 vaccine, the announcement that Ken Frazier will step down as CEO at Merck & Co. and why approval of aducanumab is so critical for Biogen.